Regenerative Medicine

IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. With a mission to accelerate innovation for a healthier world and a vision to power smarter healthcare for everyone, everywhere, IQVIA leverages unparalleled data, transformative technology, and deep healthcare expertise to drive better patient outcomes. Operating in over 100 countries with approximately 88,000 employees, IQVIA supports pharmaceutical, biotech, medtech, public health, and government organizations with a comprehensive portfolio of services and solutions. The company is recognized for its Connected Intelligence™, healthcare-grade AI, and commitment to sustainability, innovation, and evidence-based insights that shape the future of healthcare globally. IQVIA is also dedicated to reducing health inequities and driving sustainable change through innovation, collaboration, and data-driven solutions, partnering with organizations worldwide to address complex healthcare challenges.

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.

FiteBac Technology/FiteBac Pharma's K21 uniquely targets the underlying disease state, given that most diseases involve microbial-associated inflammation and mitochondrial dysfunction. FiteBac Technology innovations stem from the work of numerous international academic research scientists. FiteBac Pharma K21 is the blockbuster antimicrobial small molecule designed to modulate biological, immunological, and metabolic systems for treating a wide range of infectious and inflammatory diseases. This patented drug substance has demonstrated the ability to safely eliminate bacterial, fungal, and viral infections, enhance innate immunity, induce mitophagy while improving mitochondrial and cellular metabolism, accelerate wound healing, and even promote the development of zebrafish and chickens, leading to increased adult mass. Rigorous research from Dr. Bhupesh Prusty's laboratory and Dr Christopher Rongo's laboratory is focused on various aspects of mitochondrial remodeling and reprograming, as well as mitochondrial-to-nuclear signaling with K21.

Humanetics Corporation is a clinical-stage pharmaceutical company based in Minneapolis, Minnesota, focused on developing and commercializing products to enhance human health and wellbeing. Founded in 1988, the company specializes in radiation modulators, adjunctive oncology therapies, and pulmonary protective therapies, particularly for COVID-19. Humanetics is known for its lead drug candidate, BIO 300, which is being developed as a radioprotectant for military and civilian use, as well as a treatment to improve outcomes in cancer patients receiving radiotherapy. The company is actively engaged in research programs for non-small cell lung cancer, prostate cancer, and head and neck cancers.

NervGen Pharma Corp is a clinical-stage biotech company focused on developing innovative treatments to enable nervous system repair in cases of traumatic injury and disease. Their lead drug candidate, NVG-291, is currently being evaluated in a Phase 1b/2a clinical trial for spinal cord injury, with additional preclinical evaluations for conditions such as ischemic stroke and amyotrophic lateral sclerosis (ALS). The company is also advancing a new development candidate, NVG-300, in preclinical studies.

VirTech Bio is an early-stage biotechnology company based in Natick, Massachusetts, focused on developing a human-derived hemoglobin-based oxygen carrier (HBOC) for use as a temporary blood substitute in trauma and transplantation. The company leverages expertise in hemoglobin polymerization to address critical needs in emergency medicine and organ preservation, with a pipeline also targeting veterinary and research applications. Process innovations allow scalable and contract-based manufacturing, supported by significant non-dilutive funding from the US Department of Defense and private investment.

Maverick Labs is a U.S.-based biotechnology and materials science company specializing in advanced protein design, synthetic biology, and microbial engineering. The company operates through three tightly integrated subsidiaries—Maverick Metals, Maverick Energy, and the Maverick Bio-Gene Therapy Translational Unit—each of which applies a shared technological foundation to tackle critical challenges across national defense, energy independence, and strategic material access. Together, they develop scalable, field-ready solutions that reinforce the United States’ industrial resilience and military readiness through biotechnology-driven innovation.

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat antibiotic-resistant and difficult-to-treat bacterial infections. With a focus on addressing the global antibiotic resistance crisis, Armata leverages its proprietary bacteriophage-based technology to develop high-impact, best-in-class phage therapeutics. The company operates from a 56,000 square foot facility in Los Angeles, California, equipped for phage product development from bench to clinic. Armata's team of microbiologists and scientists work on discovering natural phages and enhancing them through synthetic biology and engineering to create tailored drug products for clinical trials.

The American Burn Association (ABA) is a multidisciplinary organization dedicated to improving the lives of those affected by burn injury. With over 3,000 members worldwide, ABA focuses on promoting and supporting burn-related care, prevention, education, and research. The association brings together professionals from various disciplines to advance quality care, advocate for prevention, provide educational resources, and foster research in the field of burn injuries. ABA is also recognized for its leadership in advocacy, professional development, and the establishment of best practices and guidelines for burn care. The ABA regularly hosts conferences, develops clinical guidelines, and partners with organizations to raise awareness and improve outcomes for burn survivors.

Pulsara is a purpose-driven healthcare technology company focused on improving the lives of patients and caregivers through innovative, real-time communication and collaboration. Their telehealth platform connects clinicians, EMS, hospitals, and emergency management teams on a single patient channel, enabling dynamic, scalable, and secure care coordination for any illness or injury. Pulsara's evidence-based solutions are designed to reduce treatment times, lower costs, and enhance experiences for both patients and providers. The company is recognized for its customer-first values, award-winning support, and commitment to privacy, security, and interoperability.

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.

SanaHeal is dedicated to developing next-generation bioadhesive technologies inspired by nature to solve significant challenges in healthcare. Their innovative solutions are designed to adhere to wet and uneven surfaces, providing rapid and robust adhesion for various medical applications.

SERDA Therapeutics is a clinical stage biopharmaceutical company focused on developing innovative solutions for wound care, particularly in the treatment of burn injuries and chronic ulcers. The company aims to provide fast and effective therapeutic debridement through its proprietary enzymatic product, SN514, which is designed to enhance healing by selectively removing necrotic tissue.

Sonogen Medical Inc. is dedicated to researching, developing, and commercializing next-generation ultrasonic bone fracture healing technology. The company combines expertise in fluid mechanics, biophysics, sonar, and medical ultrasound to create safe and effective devices for bone healing.

The Institute for Integrative & Innovative Research (I3R) at the University of Arkansas is dedicated to pioneering solutions to complex societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I3R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.

Neuraptive Therapeutics is a biotechnology company focused on developing novel therapies to improve outcomes in peripheral nerve injuries (PNI). Their mission is to enhance the quality and speed of recovery for patients suffering from traumatic injuries or undergoing reconstructive surgeries, utilizing innovative technologies such as NTX-001, a nerve fusion system, and specialized microsurgical instruments.

Spartan Medical is a medical solutions company serving VA medical centers, Department of Defense (DoD) facilities, civilian hospitals, and ambulatory surgery centers across the United States and internationally. The company specializes in advanced medical devices, surgical solutions, and support services, with a history of adapting to emergent healthcare challenges and logistical demands. Spartan Medical has provided solutions in public health crises, such as COVID-19 mitigation, and delivers comprehensive procurement, logistical, and operational support for healthcare organizations. It operates as a certified Service-Disabled Veteran-Owned Small Business (SDVOSB) and is recognized for its significant presence in federal healthcare contracting.

The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.

Memsel is a biotechnology research and development company dedicated to enhancing health and combatting infections through advanced phage therapies and targeted delivery systems. The company aims to transform healthcare solutions across human, animal, and plant domains, addressing critical health challenges and antibiotic resistance.

Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.

Ceria Therapeutics is a privately held biotechnology company focused on developing novel RNA-based drug products for the treatment of acute and chronic inflammatory diseases. The company aims to address high unmet medical needs by targeting the root causes of dysregulated inflammation, thereby restoring natural healing processes and improving patient outcomes. Its core technology leverages nanoparticle delivery of microRNA therapeutics to modulate inflammatory pathways. Ceria operates research and development facilities in Tucson, Arizona and Aurora, Colorado, and collaborates with leading academic and clinical partners to advance preclinical and clinical programs for conditions such as acute lung injury, diabetic foot ulcers, and inflammatory bowel disease.

Cooper University Health Care is a regional academic health system recognized for comprehensive clinical services, advanced multidisciplinary care, specialized surgery, and robust research in South Jersey. It provides integrated healthcare across general and specialty domains, including cancer, neurosciences, cardiology, trauma, genetics, addiction medicine, and complex surgical procedures, supported by leading technologies and a network of modern facilities.

Sunflower Therapeutics is a women-owned and led biotechnology public benefit corporation founded in 2018, dedicated to democratizing access to protein manufacturing worldwide. The company develops next-generation, automated, and fully-integrated protein manufacturing solutions that simplify the process from discovery to full-scale biomanufacturing. Their mission is to make high-quality, cost-effective therapeutics, vaccines, and protein-based products accessible globally, especially in low- and middle-income countries, by leveraging innovative technologies, sustainable practices, and intuitive equipment. Sunflower’s vision is to transform the global health landscape by enabling more medicines and protein products to reach patients and consumers everywhere. Their core technologies include efficient microbial hosts, data-driven process development, and modular manufacturing facilities, supporting agile, rapid, and cost-effective production cycles for a wide range of protein-based products.

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

Military Operational Medicine funded for PTSD, Adjustment Disorder and Pain and Sleep (over $5m). 3 trials in progress. Sana Health is an FDA Breakthrough Designated Device, currently in front of the FDA for Neuropathic Pain as a de novo - expecting to be on market Q4 2025. Sana is a wearable audiovisual neuromodulation device, that provides anxiety and pain relief, and sleep on demand. $25m raised to date, and in the middle of a Series A extension SAFE note round.

Entropia Labs focuses on advancing functional medicine and wellness therapeutics through AI-driven molecular design and delivery technologies. The company aims to close the gap between promising treatments and rigorous scientific validation, with an emphasis on health-span extension.

Kane Biotech is a Canadian-based biotechnology company focused on the research, development, and commercialization of products that prevent and remove microbial biofilms. Established in 2001, the company aims to improve human and animal welfare through innovative solutions to biofilm-related challenges and antimicrobial resistance. With a strong portfolio of 54 patents and patents pending, Kane Biotech is recognized as a leader in biofilm research and technology, and is listed on the TSX Venture Exchange under the symbol 'KNE' and on the OTC Markets under the symbol 'KNBIF'.

NuShores Biosciences LLC, founded in 2014, is dedicated to commercializing patented bone and tissue regeneration technologies developed at the University of Arkansas at Little Rock. The company aims to improve the quality of life for individuals with severe tissue regeneration needs through innovative solutions like the NuCress™ bone scaffold technology, which is designed to promote healing in large segmental bone defects.

Innospera Pharma is a privately held biotechnology company based in Montreal, focused on developing small-molecule modulators targeting G-protein coupled receptors (GPCRs), particularly GPR84 and GPR40, for the treatment of chronic, fibrotic, inflammatory, and metabolic diseases. Its pipeline includes next-generation lipid-mimetic compounds designed to address unmet medical needs, with lead candidates intended for conditions such as idiopathic pulmonary fibrosis and various cardiometabolic disorders. The company leverages extensive scientific expertise and preclinical data and is supported by investors such as Investissement Québec, Seido Capital, and Anges Québec.

Altec is dedicated to advancing human potential by developing innovative human sensing technologies that enhance health science, operational security, and human performance. Founded in 1997 by Carlo De Luca, the company focuses on translating cutting-edge concepts into practical solutions that shape our understanding of human physiology. Altec's mission is to reimagine human potential through discovery, innovation, and collaboration, making significant strides in healthcare, security, and performance enhancement.

Exponent is a multidisciplinary science and engineering consulting firm serving sectors including healthcare, energy, manufacturing, and consumer products. From medical devices, pharmaceuticals, and supplements to digital health and wearables, we deliver rigorous science that quantifies impacts on human health. Exponent helps you push the envelope on the development, deployment, safety, and effectiveness of cutting-edge drugs, devices, and diagnostics — concomitantly balancing benefits and risks. Count on our multidisciplinary, data-driven, evidence-based assessments to give you clarity on your most complex product needs and challenges. With lives on the line, innovations that support healthcare demand the highest levels of scientific rigor. Whether you’re developing a novel drug, a sturdier stent, or a faster flu test, you need clear answers to complex questions, quickly. Exponent supports our life sciences clients across the total product lifecycle by solving critical design, regulatory, safety, and market access challenges. We can collaborate with you throughout your journey, helping you navigate risks and opportunities — and optimize outcomes — with science-based strategies and specialized expertise.

Base Pair Biotechnologies specializes in custom aptamer discovery and development for research, diagnostics, therapeutics, and industrial applications. The company leverages proprietary multiplex selection, advanced bioinformatics, and chemical modification techniques to develop high-affinity and selective nucleic acid aptamers. Base Pair enables affinity reagent development, biosensor design, and molecular detection for a broad range of targets and partners across academia and industry.

The University of Cincinnati Office of Research is a premier R1 urban research institution dedicated to advancing transformative knowledge and disruptive discoveries that address real-world challenges. Guided by its Research2030 strategic plan, the Office fosters interdisciplinary collaboration, supports innovative research initiatives, and connects industry, government, and community partners with UC's thought leaders. The Office accelerates economic growth and societal impact by investing in key research strengths such as analytics, cyber, robotics, sensors, skin science, adolescence, cancer, digital humanities, infectious diseases, medical devices, neuroscience, smart cities, sustainability, urban futures, and water. With a strong commitment to transparency, compliance, and research security, the Office provides comprehensive support for faculty, students, and staff throughout the research lifecycle, ensuring excellence and integrity in all scholarly activities. Specialized programs and support offices include biosafety, animal care, research integrity, cybersecurity, human research protection, defense research initiatives, government cost compliance, and radiation safety, all designed to uphold the highest standards of ethical, safe, and innovative research. The Office also keeps the community informed and engaged through its monthly 'Findings' newsletter, highlighting impactful research, partnerships, and opportunities.

Thornhill Medical specializes in advanced medical technologies for critical care, anesthesia, respiratory therapy, and vascular diagnostics. Their core offerings address clinical needs in austere, emergency, battlefield, and transport environments, enabling mobile and integrated life support, portable anesthesia, and precise non-invasive control and measurement of blood gases. With significant expertise in both product engineering and translational clinical research, the company supports deployments worldwide, collaborates with military and civilian partners, and contributes to innovation in healthcare delivery and device interoperability.

Simbex is a leading partner in medical device and consumer health product design and development, recognized for transforming complex ideas into commercially successful solutions. With a multidisciplinary team, Simbex excels in engineering, product design, software, data analytics, and commercialization strategy, supporting innovators from concept to market. Their mission is to deliver impactful medical devices and consumer health products that improve health outcomes and quality of life. Simbex is known for its holistic approach, deep regulatory expertise, and commitment to innovation and excellence in the health technology sector. The company is also active in thought leadership, regularly publishing regulatory and reimbursement updates, and hosting educational webinars for the MedTech community. Simbex maintains a robust Quality Management System compliant with ISO 13485 and FDA 21 CFR 820, ensuring high standards in product development. The company is also committed to supporting diversity in MedTech, including initiatives for women in the sector. Simbex's leadership and advisory team bring decades of experience in biomedical engineering, commercialization, regulatory affairs, and technology innovation, further strengthening its position as a trusted partner in the MedTech ecosystem.

TRI Medical, Inc. develops and supplies educational simulation models and training services to enhance the diagnostic and manual skills of healthcare professional students and new graduates. The company focuses on providing real-time, psychomotor feedback tools for medical education programs and healthcare organizations, aiming to improve confidence, self-efficacy, and diagnostic accuracy prior to clinical practice.

The UVM An-Cockrell Lab Center for Biomedical Digital Twins is a multidisciplinary research group leveraging advanced computational methods, including machine learning, agent-based modeling, and high-performance computing, to study complex biomedical and physiological phenomena. Their mission is to bridge the gap between basic science and clinical interventions by developing digital twins and computational models that inform precision medicine, therapeutic discovery, and translational research. The lab's work spans detailed organ and disease modeling, AI-driven clinical applications, and collaborative projects such as DARPA-funded initiatives, aiming to revolutionize healthcare through technology and simulation.

Profusa, Inc. is a pioneering digital health company based in the San Francisco Bay Area, dedicated to making the body’s chemistry easily accessible to improve health and wellness. Profusa develops tissue-integrating biosensors for continuous, real-time monitoring of body chemistries, empowering individuals and clinicians with actionable, medical-grade data to transform personal health management and disease prevention. Their unique bioengineering approach overcomes the foreign body response, enabling long-term, in-body monitoring through tiny, flexible biosensors that become one with the body. Profusa’s technology platform supports both consumer and medical applications, with a vision to revolutionize personalized medicine and digital health. The company is supported by significant grant funding from agencies such as DARPA and NIH, and collaborates with leading academic, hospital, and industry partners worldwide.

Blood Centers of America (BCA) is the largest blood supply network in the United States, comprising over 60 independent community blood centers that collectively distribute approximately 50% of the nation's blood supply. BCA supports member organizations through supply chain solutions, donor recruitment, advocacy, disaster response, and purchasing power. In addition to providing whole blood, red blood cells, platelets, plasma, cells, and tissues for therapeutic, diagnostic, research, and advanced therapy applications, BCA and its network are engaged in the development and delivery of advanced therapies including cell and gene therapy starting materials, processing, and manufacturing. BCA actively mobilizes resources in response to national emergencies, pandemics, and technological advances in donor experience and biotherapeutics.

Solventum is a healthcare company dedicated to enabling better, smarter, and safer healthcare solutions. With a legacy of innovation, Solventum focuses on improving patient outcomes through advanced medical technologies, oral care solutions, health information technology, and purification and filtration systems.

RION is a clinical-stage regenerative medicine company based in Rochester, MN, focused on revolutionizing exosome science to heal from within. Established in 2017, RION leverages the unique properties of exosomes derived from platelets to develop innovative therapies aimed at enhancing tissue regeneration and addressing various medical challenges.

Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue. The company aims to restore people's bodies and their self-belief by using technology to take the limits off living. With a commitment to medical education and improving patient outcomes, Smith+Nephew operates in over 100 countries and is dedicated to sustainability and community health. Their purpose is to promote health and wellbeing, not just through their products but also by ensuring a positive impact on society and the environment. Smith+Nephew is also committed to increasing diversity within the medical device industry through initiatives like the Orthopaedics for All global advisory board.

MediView XR, Inc. is a Cleveland, Ohio-based med-tech company pioneering the use of augmented reality (AR) and mixed reality to transform medical imaging, surgical navigation, and patient care. Their mission is to advance healthcare delivery with intuitive visualization, seamless collaboration, and evidence-based insights. MediView’s vision is to simplify, democratize, and inform healthcare delivery by unlocking the full potential of 3D data for image-guided procedures. Through partnerships with leading organizations such as GE HealthCare, Mayo Clinic, and Microsoft, MediView delivers AR-powered visualization and navigation solutions that provide clinicians with unprecedented 3D "X-ray vision," real-time collaboration, and improved procedural accuracy. The company is recognized for its innovative approach to addressing health equity by expanding access to advanced care, especially in rural and underserved communities. MediView’s technology is also making significant strides in medical education, enabling immersive, hands-on learning and remote collaboration for students and clinicians.

The University of Maryland, Baltimore (UMB) is Maryland’s public health, law, and human services university. It is dedicated to improving the human condition and serving the public good through education, research, clinical care, and service. UMB is the founding campus of the University System of Maryland and offers a wide range of professional degrees in health care, human services, and law.

The University of North Carolina Wilmington (UNCW) is a top doctoral and research institution located in Wilmington, North Carolina. Established in 1947, UNCW has grown to serve nearly 18,000 students and employs about 2,500 staff. The university is dedicated to providing a powerful academic experience that fosters creative inquiry, critical thinking, and thoughtful expression in a beautiful coastal setting. UNCW is committed to educational excellence, community engagement, and global connections, making it a vibrant part of the southeastern North Carolina community. UNCW also emphasizes the importance of freedom of expression and mutual respect within its diverse community.

CorNeat Vision is dedicated to developing innovative biomimetic medical solutions aimed at addressing unmet medical needs across various therapeutic fields. Their mission is to harness biomimicry to improve health and equality worldwide, focusing on creating permanent, synthetic implants that integrate seamlessly with human tissue.

CellBios is a biotechnology company specializing in the design, development, and manufacturing of single-use bioprocessing and medical device solutions for healthcare, biotechnology, and regenerative medicine sectors. The company operates GMP and ISO-certified cleanroom facilities, offering a comprehensive portfolio of cryopreservation products, bioreactors, fluid management systems, advanced packaging, and specialty devices. By leveraging expertise in extrusion, molding, assembly, sterilization, quality control, and regulatory compliance, CellBios provides customized, scalable solutions to support blood transfusion, cell and gene therapy, biologics manufacturing, and clinical workflows.

The University of Missouri-Kansas City (UMKC) is dedicated to transforming today's learners into tomorrow's leaders through innovative education, research, and community engagement. With over 125 academic programs, UMKC fosters a diverse and inclusive environment that empowers students to achieve their goals and make a positive impact in their communities.

Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world, dedicated to providing high-quality, patient-centered care. With a history of innovation spanning nearly 150 years, Mayo Clinic is committed to transforming healthcare through research, education, and compassionate care, ensuring that the best possible treatment is available to everyone.

Michigan Engineering combines top-tier engineering education with advanced research and state-of-the-art facilities, supporting both undergraduate and graduate students. The college emphasizes hands-on and experiential learning, interdisciplinary collaboration, and research strengths in areas such as robotics, energy, sustainability, precision medicine, cybersecurity, space systems, and computational science. Advanced laboratories are available for internal and external users, reflecting a commitment to innovation, industry partnerships, and technology transfer.

Draper is an independent nonprofit engineering innovation company with a legacy spanning over 90 years, dedicated to delivering transformative solutions for national security, prosperity, and global challenges. Renowned for its pioneering work in guidance, navigation, and control (GN&C) systems, Draper partners with government, industry, and academia to engineer advanced technologies in space, defense, biotechnology, and electronic systems. The company leverages multidisciplinary expertise, digital engineering, and a collaborative approach to provide field-ready prototypes, mission-critical systems, and innovative research. Draper’s mission is to ensure the nation's security and prosperity by delivering sustainable, cutting-edge solutions that address the toughest problems of today and tomorrow, while fostering an inclusive and diverse workforce. Draper also invests in the next generation of innovators through robust educational programs, including internships, co-ops, and the Draper Scholars Program, integrating academic research with real-world problem-solving.

Since its founding in 1878, Shionogi has been dedicated to developing innovative treatments to improve the lives of patients worldwide. The company focuses on addressing global health challenges, including antimicrobial resistance and COVID-19, through a commitment to scientific excellence and strategic partnerships.

ARMR Sciences, Inc. is a biotechnology company dedicated to ending the fentanyl crisis and defending against synthetic drug threats through American innovation. The company is pioneering scalable, preventative immunotherapies to protect individuals before exposure to lethal synthetic drugs like fentanyl, moving beyond reactive treatments to address the root causes of overdose deaths. ARMR's technology is supported by foundational licenses from the Department of Defense and aligns with federal health and defense agencies. The multidisciplinary team brings significant experience from leading institutions and companies such as MindMed, iBio, Ridgeback Biotherapeutics, Scripps Research, Boston Children’s Hospital, Harvard Medical School, and more. United in their vision to save lives, ARMR is committed to providing lasting protection and solving the overdose crisis for millions in need.

Micron Biomedical is a clinical-stage life science company and the leader in dissolvable microarray-based technology for needle-free delivery of vaccines and therapeutics. The company's mission is to radically expand access to treatments and vaccines, improve global health outcomes, and transform how vaccines and drugs are administered. Micron's proprietary technology enables painless, thermostable, and self-administered drug and vaccine delivery, eliminating the need for cold chain logistics and reducing infrastructure barriers. The company is recognized for its innovative approach to overcoming vaccine hesitancy and access challenges, and is rapidly advancing toward commercializing its technology for global impact. Micron partners with leading global health organizations and has secured significant funding to accelerate the development and commercialization of its needle-free solutions.

Adipothera develops therapies targeting the stromal microenvironment to treat diseases driven by fibrosis and inflammation. Using AI, computation, and multi-modal datasets, the company generates and validates drug candidates aimed at repairing tissue rather than managing symptoms. Their approach focuses on stromal reprogramming for conditions such as radiation injury, lymphedema, and pathological bone formation.

Temple University is Philadelphia’s only public university and a global center of academic excellence. It is classified as an R1 institution, indicating very high research activity, and offers over 600 academic programs across 17 diverse schools and colleges. The university is committed to providing accessible education that fosters positive change and prepares students to become leaders in their fields. Additionally, Temple emphasizes a vibrant campus life enriched by arts, culture, and a commitment to diversity and inclusivity. The university also promotes a tobacco-free environment to enhance the health and well-being of its community. Temple's athletics program further enhances student life, with 19 varsity teams competing at the NCAA Division I level, fostering school spirit and community engagement.

DesiCorp, Inc. is pioneering the development of thermally stable packed red blood cells, revolutionizing battlefield medicine and blood transfusion technology. Their innovative solutions enable rapid and reliable care, allowing medics to administer life-saving transfusions within minutes of injury. With advancements that allow blood to be stored for years, DesiCorp is addressing critical medical challenges in trauma care.

The Office of Sponsored Projects Administration (OSPA) at the University of Kentucky is dedicated to transforming tomorrow by streamlining grants and contracts. OSPA provides essential services to faculty and staff, including assistance with proposal preparation, award negotiation, and compliance with sponsor policies.

Southwest Research Institute (SwRI) is a nonprofit research and development organization that provides independent, premier services to government and industry clients. Founded in 1947, SwRI is committed to advancing science and technology to benefit humanity, focusing on innovative solutions that improve human health and safety. With a diverse range of technical divisions, SwRI addresses complex challenges in various fields including mechanical engineering, materials, aerospace, automotive, biomedical, and more.

BioFactura, Inc., based in Frederick, Maryland, is a biopharmaceutical company specializing in the development and commercialization of high-value biosimilars, biodefense medical countermeasures, and novel drugs. Leveraging its proprietary StableFast™ Biomanufacturing Platform, BioFactura delivers faster, lower-cost, and superior-quality biologics. With over a decade of experience, the company has advanced life-saving medicines from research to patient care, focusing on unmet global biomedical and national biodefense needs. Its portfolio includes drugs for smallpox, Ebola, cancer, autoimmune, and infectious diseases.

Combat SNS (Combat Medical Consulting, CMC) is a Service-Disabled Veteran-Owned Small Business (SDVOSB) dedicated to bridging the gap between innovative medical technologies and operational end users in the Department of Defense (DoD), Department of Veterans Affairs (VA), and other government agencies. With over 30 years of expertise in direct sales, government procurement, and market integration, CMC specializes in high-quality medical supply distribution, consulting, and product development. Their mission is to accelerate the adoption of advanced medical solutions, ensuring best-value procurement and broad impact across public health and defense sectors. CMC is recognized for its comprehensive approach, from market research and product validation to training, certification, and field deployment.

NTx Bio (Nature’s Toolbox, Inc.) is revolutionizing biomanufacturing by enabling on-demand, decentralized, and scalable production of high-quality RNA and proteins. Our mission is to democratize access to medicines by overcoming the bottlenecks of traditional, centralized manufacturing. Through proprietary, synthetic biology platforms like NTxscribe® (mRNA production) and NTxpress® (cell free protein production), NTx empowers researchers and companies to accelerate the development and delivery of personalized and mass-scale therapeutics, making next-generation medicine more accessible, sustainable, and efficient, while eliminating supply chain concerns by using 100% domestic inputs and production capabilities.

Pennington Biomedical Research Center, a campus of the LSU System, is a global leader in medical discovery and translational science. Pennington Biomedical is dedicated to understanding the biological triggers of disease and nutrition-related conditions. Through basic, clinical, and population research, Pennington Biomedical pursues a bold vision: to lead the world in promoting nutrition and metabolic health and eliminating metabolic disease through scientific discoveries that deliver solutions from cells to society. Building on this foundation, Pennington Biomedical has become a trusted partner in human performance science, with over 30 years of collaboration with the Department of War and a legacy of more than 170 military-focused research projects. This expertise now extends to spaceflight, where Pennington Biomedical seeks to address the physiological demands of long-duration missions. At the forefront of these efforts is the Center for Human Performance Optimization, which unifies military and spaceflight performance science to drive cross-domain innovation. The Center conducts multidisciplinary research to understand and enhance human capabilities under extreme stress. Research spans clinical trials, operational studies, and advanced analytics, with integrated approaches across nutrition, exercise, sleep, pharmaceuticals, cognitive health, and emerging technologies. Studies focus on preventing performance decline and pushing the boundaries of human potential in the harshest environments. Pennington Biomedical’s world-class infrastructure supports this mission. The Clinical Trials Unit includes a 90,000-square-foot outpatient clinic, a 20-bed inpatient unit with metabolic chambers and sleep labs, a metabolic kitchen, dedicated exercise facilities, and flexible-use research space. These resources enable rigorous, multidisciplinary trials. The CTU is further supported by advanced imaging, biochemistry, and data management cores, as well as animal research platforms focused on metabolism, behavior, and comparative biology. Through its integrated platforms and mission-driven focus, Pennington Biomedical is shaping the future of human performance science. The Center for Human Performance Optimization delivers real-world impact for national defense, space exploration, and elite human capability—ensuring warfighter readiness, astronaut resilience, and human excellence across the most challenging environments.

The Israel Innovation Authority is the central governmental body responsible for fostering and advancing Israel's innovation ecosystem. Its mission is to power innovation through investment, insight, and impactful programs, supporting high-tech entrepreneurship, deep-tech ventures, and global collaborations. The Authority provides non-dilutive funding, strategic support, and regulatory guidance to startups and established companies, ensuring Israel remains a global leader in technology and innovation. With a focus on sectors such as AI, bioconvergence, foodtech, climate tech, and more, the Authority bridges academia, industry, and international partners to address humanity's pressing challenges and drive economic growth. Israel's tech ecosystem, often called the "Startup Nation," is characterized by a culture of bold experimentation, interdisciplinary collaboration, and resilience, making it a global powerhouse for innovation. The Authority also plays a pivotal role in shaping national innovation policy, supporting R&D, and facilitating co-investment opportunities for international investors. The Authority's unique features include proactive future-readiness, risk-absorbing investment models, global market integration, and resilience in times of crisis, such as the deployment of Fast-Track bridging funds to protect startups. The Authority also operates innovation centers and manufacturing accelerators to expand high-tech opportunities geographically and demographically, and regularly identifies and supports emerging technologies with high potential impact. The Authority supports a vast portfolio of startups and scale-ups across diverse sectors, including medical engineering, software, electronics, foodtech, biotech, and more, through programs such as Tnufa, Technological Incubators, R&D grants, and international collaborations.

AvantGuard has developed a novel broad-spectrum, bio-compatible antiseptic that is proven in in vitro, ex vivo, and in vivo testing to be safe and more effective than topical antibiotics, while also effective as a liquid sterilant or disinfectant. Our compound, Avantamine, can be packaged as a heat-tolerant, long-shelf-life powder in a metal foil packet that dissolves rapidly in potable water to make either a solution or hydrogel. At a high concentration, Avantamine's non-hazardous, non-corrosive solution will sterilize medical equipment in 10 minutes and is safe enough for instruments to be removed and used without rinsing. Diluted by half, Avant24 at 0.6% concentration is (1) an antiseptic for washing wounds or treating cutaneous bacterial and fungal infections, (2) a high-level disinfectant for a variety of medical devices without corroding metals or degrading plastics, and (3) a disinfectant for surfaces in the surgical suite. At 6X further dilution, Avant24 can treat trench mouth. At another 3X dilution, Avant24 can be added to water to make it drinkable. There are an enormous number of potential uses and the only difference between them is the amount of diluent, in this case water, used to prepare the solution. Our military focus areas are (1) low resource sterilization of medial devices, (2) fungal treatment for burn wounds, and (3) a prophylactic for infection control in a self-administered Role 1 environment with the powder applied directly to a wound. Our commercial focus area is Candida auris decolonization which is not currently possible with any other antiseptic. We have definitive animal testing to show efficacy and superiority to chlorhexidine and are moving toward the clinic.

The Southwest Texas Regional Advisory Council (STRAC) is dedicated to developing, implementing, and maintaining a regional trauma and emergency healthcare system for the 22 counties in Trauma Service Area – P. STRAC aims to reduce death and disabilities related to trauma, disaster, and acute illness through well-coordinated emergency response systems, striving to be a model for emergency healthcare in the United States.

Paracrine develops regenerative therapies for chronic wound care, leveraging autologous cell-based treatments and real-time AI platforms to enhance healing precision, predictability, and efficiency. The company operates globally, focusing on scalable and cost-effective biological solutions that integrate advanced machine learning for improved patient outcomes.

The University of Arizona Applied Research Corporation (UA-ARC) is a non-profit organization affiliated with the University of Arizona, dedicated to leveraging the university's strengths in research and education to address national security challenges. UA-ARC aims to deliver innovative solutions and foster collaborations between academia, industry, and government.

Frontier Bio creates lab-grown human tissues to reduce the worldwide organ shortage. Their first clinical product is a tissue-engineered vascular graft made from the patient's own cells.

The University of Utah (UU) is a leading research institution recognized for its research activity and commitment to innovation and discovery. As an R1 Institution, it is dedicated to advancing knowledge and solving critical problems that challenge our national security interests and impact the global community. We foster interdisciplinary collaboration and provide resources to drive transformative research focused on enhancing medical care superiority for the U.S. Department of Defense (DoD) through advanced medical and engineering research sponsored by our Applied Medical & Engineering Laboratory (AM&E Lab). As a leading public university, UU also provides healthcare services to seven states in the Intermountain West, with the largest catchment of remote and austere frontier territory for any academic center. Leveraging its geographic advantage, technological and commercialization strengths, expertise in medical services, and leading-edge, core engineering competencies, UU is uniquely positioned to address the nation's critical national security interests.

The Institute for Biohealth Innovation (IBI) at George Mason University unites over 300 faculty and thousands of students across 34 departments to advance human health and well-being through innovative research. The IBI focuses on major health challenges, including infectious diseases, cancer, brain and behavior, and cardiovascular health, collaborating with national and international partners to implement solutions that enhance health outcomes.

Inflammasense specializes in advancing healthcare and clinical research through the integration of neural and molecular biomarkers. By leveraging continuous, real-time physiological and molecular data, the company aims to facilitate precision treatments, accelerate clinical trials, and enhance early detection and prevention of critical illnesses such as sepsis and hemodynamic compromise. Their technology platforms including the wearable VITALX-PATCH and Point of Care micro-RNA Handheld Ultra-sensitive Biomarker Sensor (HUBS) systems support clinical trials, defense, and corporate wellness sectors, with a focus on expedited objective decision-making and scalability. The company has secured $4.05 Mil in non-dilutive funding from DARPA, BARDA and the NIH, while it has now closed a total of 1.65 Mil in dilutive funding from KittyHawk Ventures (Pre-seed of $250K) and private investment of (Seed $1.5 Mil). The 2 years long Pre-Seed funding is scoped to obtain FDA 501 (k) clearance of the VITALX-PATCH and initiate FDA submissions for the HUBS device. InflammaSense is seeking $7.5 Mil investment for the clinical trials and product manufacturing to scale for DeNovo approved devices. The approved device is indicated for the first beach head use case as a companion diagnostic for individualized Sepsis therapy.

Senphonix is a MedTech startup dedicated to transforming patient monitoring through intelligent, automated, and continuous vital signs tracking. Their mission is to close the gap between data and action in healthcare, enabling precision, clarity, and compassion for patients, clinicians, and healthcare systems. By leveraging breakthrough wearable technology and secure, cloud-based software, Senphonix aims to reduce clinician burden, improve patient outcomes, and drive efficiency across the continuum of care. The company is headquartered in Minnesota and Arizona, and collaborates with leading academic and healthcare partners to bring next-generation solutions to market.

The University of Minnesota's Research and Innovation Office (RIO) serves as a central resource for conducting, managing, and sponsoring research. It aims to facilitate collaborative research that addresses complex problems and promotes innovations that improve lives. RIO oversees research compliance and administration, fostering a culture of integrity and ethical practices in research. Additionally, RIO is committed to enhancing research capacity through various funding opportunities and strategic initiatives, including the management of specialized facilities for biocontainment research.

The University of Notre Dame, founded in 1842, is a prestigious Catholic research university located in South Bend, Indiana. It is dedicated to providing a holistic education that integrates faith, reason, and service to others. The university aims to be a leading global Catholic research institution, fostering a community of scholars committed to inquiry, justice, and the common good.

New York University (NYU) is a global university that connects talented and ambitious individuals in some of the world's greatest cities. Its mission is to be a top-quality institution, providing a diverse range of academic programs and opportunities for students to engage with the world's challenges. NYU is committed to fostering innovation and entrepreneurship, and it emphasizes diversity, equity, and inclusion in its educational mission. Founded in 1831, NYU has evolved to become a leader in higher education, with a commitment to accessibility and a diverse student body. NYU offers a wide array of academic programs, including accelerated studies and online education, catering to the needs of a global student population.

ReliOx Corporation is a U.S.-based advanced materials and medical technology company with a clean oxidation platform for on-demand generation of pH-neutral aqueous chlorine dioxide. The ReliOx platform enables safe, controlled oxidation at the point of use without acids, electricity, or hazardous intermediates—addressing long-standing limitations that have historically prevented chlorine dioxide from being used routinely in medical and operational environments. ReliOx directly supports the important core objectives aligned with MTEC members: improving trauma care, reducing infection risk, enabling care in austere and resource-constrained settings, and accelerating transition of dual-use technologies from non-regulated markets into regulated medical and defense applications. The platform’s defining feature is not a new chemical agent, but a novel generation method that produces true chlorine dioxide only at the moment of use, in a neutral pH aqueous form compatible with tissue, metals, polymers, elastomers, and sensitive electronics. ReliOx is advancing an initial wound cleansing and irrigation use case that aligns closely with military and emergency medicine needs, including contaminated wounds, blast injuries, and prolonged field care. The system’s on-demand architecture eliminates the need to store reactive disinfectants, reduces logistical burden, and supports distributed medical operations, a priority across DoD, BARDA, and ONR programs. This makes the platform particularly relevant for battlefield medicine, forward surgical teams, and humanitarian or disaster response scenarios. In parallel, ReliOx operates VetiOx, a veterinary-focused pathway that applies the same platform to animal wound care (including equine). This strategy generates early operational data and clinician familiarity while remaining aligned with long-term human medical translation—an approach consistent with MTEC’s emphasis on de-risking technologies prior to advanced development. The ReliOx platform is inherently dual-use. All commercial, veterinary, food safety, and medical applications share the same resin-based generation mechanism, enabling efficient manufacturing, rapid scaling, and consistent safety characteristics across use cases. This platform approach allows ReliOx to support incremental transition from non-regulated and veterinary markets into FDA-regulated medical devices and DoD-relevant medical countermeasures without fundamental redesign. ReliOx represents a strong MTEC-aligned opportunity at the intersection of advanced chemistry, trauma care, infectious disease mitigation, and distributed manufacturing. The company offers a defensible intellectual property position, a clear regulatory strategy, and a near-term path to operational relevance for military medicine and biodefense stakeholders .

The Wyss Institute for Biologically Inspired Engineering uses biological design principles to develop new engineering innovations that will transform medicine and create a more sustainable world. At the Wyss Institute, we leverage recent insights into how Nature builds, controls and manufactures to develop new engineering innovations - a new field of research we call Biologically Inspired Engineering. By emulating biological principles of self assembly, organization and regulation, we are developing disruptive technology solutions for healthcare, energy, architecture, robotics, and manufacturing, which are translated into commercial products and therapies through formation of new startups and corporate alliances.

Remedor Biomed is a clinical research stage biopharmaceutical company focused on revolutionizing complex wound treatment through patented technology. The company aims to provide innovative solutions for diabetic foot ulcers and complex skin wound conditions, significantly impacting patients' lives and healthcare systems.

ATD Emolda has been delivering innovative solutions for 40 years, specializing in the conversion and manufacturing of components and assemblies for industrial, medical, and pharmaceutical applications. The company has become a thought leader in advanced wound care materials, focusing on developing high-performance polyurethane foams and silicone adhesives.

Cayuga Biotech is dedicated to harnessing the body's innate ability to halt bleeding and heal, addressing significant unmet needs in hemorrhage control and bleeding disorders through proprietary science and innovative solutions.

Vasomune Therapeutics is a private clinical-stage biopharmaceutical company focused on developing novel therapeutics for diseases associated with vascular dysfunction. Their lead drug candidate, Pegevongitide (AV-001), enhances the body's ability to reverse vascular endothelial instability and vascular leak, particularly in conditions such as Acute Respiratory Distress Syndrome (ARDS), hemorrhage, and following toxin exposure.

Northwestern University is a prestigious institution dedicated to fostering a diverse and inclusive environment, promoting academic excellence, and engaging in impactful research. With campuses in Evanston, Chicago, and Doha, Qatar, Northwestern emphasizes global engagement and community involvement, preparing students to tackle complex challenges through interdisciplinary collaboration and innovative thinking.

The University of Iowa is dedicated to providing a comprehensive educational experience that fosters academic excellence, research opportunities, and a vibrant student life. With a commitment to accessibility and inclusivity, the university aims to prepare its students for success in various fields while promoting a supportive community.

Case Western Reserve University is dedicated to solving the biggest issues of today and tomorrow through innovative research and education. With a commitment to experiential learning, the university offers a wide range of programs and opportunities for students to engage in research, internships, and community service, all within a vibrant campus located in Cleveland, Ohio.

The Henry M. Rowan College of Engineering at Rowan University is a leader in engineering education, research, and innovation. With a mission to advance fundamental and applied science and engineering technology, the college emphasizes responsible use of both renewable and fossil resources to enhance material performance and global sustainability. The college fosters a diverse, collaborative environment that educates and trains the next generation of scientists and engineers, while engaging in impactful research, industry partnerships, and community outreach.

The University of Alaska Fairbanks (UAF) is a Land, Sea, and Space Grant university and an international center for research, education, and the arts, emphasizing the circumpolar North and its diverse peoples. UAF integrates teaching, research, and public service as it educates students for active citizenship and prepares them for lifelong learning and careers.

New Jersey Institute of Technology (NJIT) is a leading public research university dedicated to providing students with a world-class education in STEM fields and beyond. With a commitment to academic excellence, NJIT prepares students to be leaders in the most in-demand fields through innovative programs, expert faculty, and extensive research opportunities. NJIT is recognized for its affordability and return on investment, making it a top choice for students seeking a quality education. NJIT is also ranked among the top public universities in the nation, known for its diverse student body and commitment to fostering an inclusive environment.

Polaroid Therapeutics is a Swiss-based biotech start-up, established in 2022 and incubated by the iconic Polaroid brand. The company is dedicated to addressing major challenges in antimicrobial therapies through cutting-edge technology and research. Its mission is to create a more human, meaningful, and healthier world by developing proprietary antimicrobial polymer technologies that reduce bioburden, improve patient outcomes, and do not trigger antimicrobial resistance (AMR). Polaroid Therapeutics focuses on advanced wound care, medical device coatings, and holistic therapeutic applications, aiming to set new standards in patient-centric care and global health.

The University of Arkansas for Medical Sciences Office of Research and Sponsored Programs (ORSP) is dedicated to supporting UAMS faculty in acquiring, performing, and administering projects funded by external sources. The ORSP ensures compliance with policies, negotiates award terms, liaises between investigators and sponsors, and manages subcontracts.

Modulim is dedicated to preventing the complications of chronic wounds due to diabetes, peripheral arterial disease, and burns. Mapping tissue health at the point-of-care is key to preventing non-healing chronic wounds. This is made possible only by Modulim's handheld microvascular imaging solution, powered by Spatial Frequency Domain Imaging (SFDI), that empowers healthcare teams with proprietary data and proactive, personalized AI insights.

Founded by Thomas Jefferson in 1819, the University of Virginia is a prestigious public university that emphasizes the advancement of human knowledge, education of leaders, and cultivation of an informed citizenry. It is recognized for its commitment to academic excellence, vibrant student life, and a strong alumni network, making it one of the top public universities in the United States.

The University of Missouri is dedicated to advancing research, innovation, and impact through a comprehensive support system for faculty, students, and staff. It aims to foster collaboration, enhance economic development, and promote entrepreneurship, while ensuring compliance with research regulations and ethical standards. The university also emphasizes the importance of interdisciplinary partnerships and provides resources to support veteran entrepreneurs through programs like the Entrepreneurship Bootcamp for Veterans.

Viscus Biologics LLC specializes in product realization from ideation to high volume production, manufacturing components, devices, and products with natural polymer and extracellular matrix materials. The company aims to fulfill patient and market needs, improve quality of life, and restore tissue to a healthy state.

Legionarius specializes in developing smart garments designed for real-time detection of wounds and hemorrhaging in high-risk environments, such as combat, action sports, and industrial operations. Their mission is to revolutionize personal safety with sensor-integrated solutions that provide immediate injury alerts and remote triage capability.

MLM Biologics Inc. is dedicated to advancing wound care through innovative solutions like the bio-ConneKt® Wound Matrix, a collagen-based product designed for effective wound closure. The company emphasizes a mission of providing more effective and economical solutions for wound healing, aligning with the Gandhian Economic Principle of 'More for Less for Many.'

The University of Massachusetts Lowell (UML) is dedicated to providing a comprehensive educational experience that prepares students for success in their careers and lives. With over 200 degree programs and a commitment to research and community engagement, UML fosters a vibrant learning environment for its diverse student body.

Aphios is a green biotechnology company focused on developing enabling nanotechnology platforms and enhanced therapeutics for health maintenance, disease prevention, and treatment of various conditions including cancers, infectious diseases, and central nervous system (CNS) disorders. The company emphasizes environmentally-sustainable practices and aims to improve the quality of life through innovative therapies.

Vivonics, Inc. is dedicated to creating innovative solutions to address unmet medical and wellness needs, focusing on mobile physiological monitoring, advanced diagnostics, non-invasive interventions, and clinical decision support technologies. Founded in 2012, the company collaborates with a network of clinical and academic partners to enhance human health and performance in various challenging environments.

The Institute for Trauma Recovery is a multidisciplinary team at the University of North Carolina at Chapel Hill focused on advancing the understanding of trauma recovery processes and developing interventions to promote rapid recovery and prevent chronic symptoms. The institute values collaboration among faculty and staff to improve care for individuals who have experienced trauma.

RTI International is an independent nonprofit research institute dedicated to improving the human condition. With a vision to address the world's most critical problems through science-based solutions, RTI integrates expertise across social and laboratory sciences, engineering, and international development to deliver reliable data, thorough analysis, and innovative methods that inform public policy and practice.

The University of Nebraska Medical Center (UNMC) is dedicated to transforming lives through premier educational programs, innovative research, and extraordinary patient care. Founded in 1869, UNMC is a leader in health sciences education and research, serving as a vital resource for Nebraska and beyond.

The University of Georgia (UGA) is dedicated to facilitating instruction, scholarly and creative activity, and research collaborations across disciplines. UGA is a leader in research-based products and innovation, significantly impacting the state of Georgia and beyond through its extensive research initiatives and academic programs.

Southern Research (SR) is a nonprofit preclinical contract research institute that has been bridging basic science and commercial solutions for over 80 years. From pioneering chemotherapy research in collaboration with Memorial Sloan Kettering to generating millions of data points in the global fight against COVID-19, SR has consistently been at the forefront of scientific innovation. Our team of experts excels in transforming cutting-edge science into tangible societal benefits, utilizing comprehensive drug discovery and development capabilities to drive innovation and advance life-saving medical breakthroughs. SR collaborates with over 100 industrial partners, the federal government, and numerous academic institutions to advance the development of life-saving medicines.

MassBiologics, part of UMass Chan Medical School, is the only nonprofit, FDA-licensed manufacturer of vaccines and biologics in the United States. With over 100 years of experience, it is dedicated to improving public health through the research, development, and production of biologic products, including vaccines and monoclonal antibodies.

TDA Research, Inc. is dedicated to addressing complex real-world problems through innovative research and development in chemical processes, materials, and hardware. With a focus on agility and collaboration, TDA partners with clients in defense, aerospace, energy, and chemical industries to deliver cutting-edge solutions and technologies.

Ceres Nanosciences, Inc. is a privately held company based in Northern Virginia, specializing in the development and commercialization of Nanotrap® hydrogel particle technology. Their mission is to deliver innovative products powered by Nanotrap Technology to address life science needs and provide better patient outcomes. Ceres' products enable the capture, concentration, and preservation of low-abundance analytes from diverse biological and environmental samples, supporting applications in diagnostics, research, and public health surveillance. The company is ISO 9001:2015 certified and collaborates with leading research institutions, public health agencies, and industry partners to advance global health security and biosecurity. Ceres has established a national network of Wastewater-based Epidemiology Centers of Excellence and has received significant funding from the NIH RADx initiative and other organizations to expand its impact in underserved communities. Their technology is widely adopted for wastewater-based epidemiology, proteomics, and nucleic acid analysis, with a strong focus on supporting public health monitoring, early detection of infectious diseases, and environmental bio-surveillance.

Cohesys is a clinical-stage company focused on innovating fracture repair solutions. Its product, BoneTape, is the first bone fixation device that does not require drilling into healthy bone. The company aims to disrupt the traditional surgical-repair industry that relies on invasive plates and screws.

The Medical University of South Carolina (MUSC) is South Carolina’s premier biomedical research institution, dedicated to advancing health through innovative research, education, and clinical care. With over $300 million in research funding and a commitment to addressing pressing health challenges, MUSC fosters collaboration among faculty, staff, and community partners to translate scientific discoveries into impactful health solutions. The South Carolina Clinical & Translational Research Institute (SCTR) at MUSC supports innovative research across the translational spectrum, from basic science to population health, including patient-centered and community-engaged research.

Nervonik is a California-based medical technology company pioneering the development of the smallest, most advanced, and power-efficient neuromodulation implants for chronic neuropathic pain. Their mission is to provide a more effective, non-narcotic alternative to opioids and complex spinal-cord stimulators, leveraging next-generation neural-sensing integrated circuits and wireless power transfer technology. Nervonik's solutions are designed to deliver optimized, personalized therapy with minimal resistance, aiming to dramatically improve the quality of life for patients suffering from chronic pain.

NeoMatrix Therapeutics is a clinical-stage company dedicated to developing novel, bioactive peptides aimed at preventing injury progression and enhancing tissue healing, particularly in severe burn cases. Founded by Dr. Richard A. Clark, the company focuses on innovative therapies that significantly improve the quality of life and clinical outcomes for burn patients.

The UCI Office of Research is dedicated to supporting and enhancing the creative and scholarly activities of UCI faculty and researchers. It provides central administrative support for research programs, ensuring compliance with regulations and fostering an environment conducive to research and innovation.

Gel4Med is a commercial-stage company pioneering the use of smart, bioinspired materials to address major challenges in medicine. Founded out of Harvard Innovation Labs, Gel4Med leverages its proprietary Smart Materials Platform™ (SMP™) to develop advanced therapeutics and devices, with a mission to enhance health outcomes and access for all patients. The company is committed to creating novel biomaterials that improve regenerative medicine and surgical solutions, and has achieved significant milestones including FDA clearance for its lead wound care product, G4Derm™ Plus.

Instant Systems specializes in the design and manufacture of single-use sterile systems for cell and gene therapy, regenerative medicine, tissue banking, and related bioprocessing applications. The company offers a wide range of customizable solutions for cell culturing, fluid management, media and waste containment, magnetic cell separation, and sterile filtration, with a focus on maintaining process integrity from production through delivery. Their products support closed-system workflows, scalability, and integration into existing manufacturing and research environments.

The Clemson University Research Foundation (CURF) is dedicated to advancing the research enterprise at Clemson University by connecting faculty and students with industry partners. CURF facilitates the commercialization of university technologies, supports research collaboration, and promotes innovation through various funding and support programs.

Virginia Tech is a leading research institution dedicated to improving the quality of life and the human condition through education, research, and community engagement. With a commitment to its motto, 'Ut Prosim' (That I May Serve), Virginia Tech fosters a collaborative environment that integrates technology into all disciplines, preparing scholars to be leaders and problem-solvers.

OsteoCure Therapeutics, a Duke University spinout and Johnson & Johnson JLABS company based in Durham, North Carolina, is developing OCTA1, a first-in-class injectable therapy designed to accelerate bone healing while simultaneously reducing pain. OCTA1 is a device led combination product that is composed of a hyaluronic acid scaffold with sustained-release microgels that deliver adenosine, a naturally occurring molecule critical for bone regeneration and pain modulation. Preclinical studies have demonstrated significant improvements in fracture healing and functional recovery, with strong statistical significance in both bone repair and analgesia. For civilian medicine, OCTA1 offers a minimally invasive, opioid-sparing solution for treating fusions, fractures, and other orthopedic trauma, enabling faster recovery for patients from athletes to older adults. In military medicine, the technology addresses critical needs in combat casualty care and training-related musculoskeletal injuries such as stress fractures, by providing a deployable, shelf-stable, and rapidly administered intervention that improves healing outcomes and reduces downtime, ultimately enhancing force readiness while also benefiting the long-term musculoskeletal health of veterans

ParaNano Wound Care, LLC is a pre-clinical MedTech company based in Oklahoma City, founded in 2018. The company is dedicated to developing and commercializing advanced wound care solutions, most notably the Bio-Z™ Smart Bandage. ParaNano holds exclusive, worldwide patent rights to foundational nanofiber and biosensor technologies licensed from the University of Central Oklahoma and the University of Manitoba. Their mission is to address the critical gap in wound care by providing real-time, continuous infection detection, empowering both clinicians and patients to intervene early and improve outcomes. ParaNano is recognized for its innovation, strategic partnerships, and commitment to health equity, and is a member of the prestigious Blue Knight program by Johnson & Johnson Innovation and BARDA.

Velico® is a private, clinical stage medical technology company headquartered in Beverly, Massachusetts, dedicated to reducing preventable death from bleeding through innovative blood and plasma products. Their flagship product, FrontlineODP™, is a novel dry plasma manufacturing system designed for rapid rehydration and transfusion in emergency settings, aiming to improve patient access to life-saving treatments.

Radiatric Inc. is dedicated to developing and commercializing innovative technologies to improve outcomes for patients with blood stream infections that can lead to sepsis, and septic shock. Antimicrobial resistance is a serious global health threat. Our flagship medical device, our RAD-01 system, is an extracorporeal non-antibiotic device designed to treat blood stream infections by targeting and killing pathogens even multi drug-resistant organisms. The company's focus is on non-pharmacological methods of killing pathogens, aiming to reduce the mortality and long-term effects associated with sepsis.

ABOUT The THOR Network Foundation The THOR (Trauma Hemostasis & Oxygenation Research) Network Foundation is a US-based 501(c)(3) public charity organization. It’s members are an international multidisciplinary network of civilian and military providers ranging from first responders and medics to physicians from multiple disciplines, as well as basic scientists, bioengineers, and clinical trialists. The international influence of THOR is evidenced by our membership of over 600 subject matter experts and industry leaders from over 31 countries from 6 continents. OUR MISSION: To develop and implement best practices for prehospital damage control resuscitation in trauma care through to the completion of the acute phase of hemorrhagic shock resuscitation at higher echelons of care. The THOR Network will execute this mission through a multidisciplinary collaborative approach to research, education, training, and advocacy. See www.thornetwork.com for more information about the THOR Network, its foundation, and the Research Institute. The THOR Research Institute (TRI) The THOR Research Institute (TRI), LLC is a subsidiary of the THOR Network Foundation. The purpose of the TRI, LLC is to facilitate medical research to improve patient outcomes in furtherance of Code Section 501(c)(3). The TRI is a Research and Development Institute specializing in translational research and advisory services. It is comprised of investigators that span the translational research pipeline that includes basic science, clinical trials, implementation science. The TRI is unique compared to many other research institutes and consulting groups in that its investigators and advisors are members of a large international multidisciplinary network with a balanced mix of established investigators, and advisors with extensive clinical experience, practical understanding, and knowledge of clinical care required for patients with hemorrhagic shock. THOR and the TRI have demonstrated its ability in performing high quality science challenging long standing dogma in resuscitation medicine that has led to substantial change in practice and improving outcomes globally. The TRI is eligible to submit funding applications for federal funding in the US for projects initiated by TRI investigators. The TRI also collaborates internationally with academia, industry, and federal agencies to perform translational research in the area of resuscitation science to support licensure applications for devices and biologics. While research and development of diagnostics and therapies for trauma-related hemorrhage is our main focus we have an interest in all etiologies of life-threatening bleeding and the use of blood products for resuscitation. TRI Capabilities/Services include the following: 1. Product and Device Development a. Program and Project Management i. Government Contracting Liaison (BARDA, DARPA, DoD) b. Chemistry, Manufacturing, and Controls development c. Right-sized Quality System development d. Pre-clinical program development for products or devices 2. Clinical Research Organization Services a. Clinical study operations for phase 1 through phase 4 trials. i. Trial design ii. Protocol development and operationalization iii. Clinical trial site identification, feasibility, qualification, selection and qualification iv. IRB/ethics and regulatory management b. Clinical program external review 3. Regulatory a. Interface, including correspondence with regulatory authorities as well as authoring and reviewing of pre-IND, IND, NDA, and BLA documentation. b. Experience with global regulatory authorities (TGA, EU, Health Canada, ANVISA) c. CDER, CBER, CDRH 4. Educational a. Development of webinars for educational purposes b. Development of focused scientific symposia 5. Consulting or advisory a. Development of advisory boards for industry, investment firms, and government entities b. Product assessment by end users for practical feedback on military and civilian applications, functionality, and potential for widespread adoption. c. Market analyses, including survey development and dissemination

Clyra Medical Technologies is a healthcare company dedicated to improving lives by developing and commercializing innovative products for wound and skin infection treatment. As a subsidiary of BioLargo, Inc., Clyra focuses on creating safe, effective, and cost-efficient solutions that reduce the need for antibiotics and promote wound healing. Their technology, based on a copper-iodine complex, offers a broad-spectrum antimicrobial effect without known microbial resistance, making it suitable for various healthcare settings.

LSU Health Sciences Center New Orleans is dedicated to educating future health professionals and scientists, advancing research, and providing exceptional healthcare. With six professional schools and numerous affiliated hospitals, LSUHSC-NO aims to improve health outcomes and address health equity challenges in Louisiana.

Vira Regen Inc. is at the forefront of biotech innovation, focusing on regenerative medicine to address the root causes of diseases and injuries. The company is pioneering the development of novel, gene-specific electroceuticals that stimulate the body's bioelectric network and genetic code, promoting accelerated healing through the body's natural self-repair processes.

The National Strategic Research Institute (NSRI) is a University Affiliated Research Center (UARC) designated by the U.S. Department of Defense, dedicated to ensuring U.S. safety and preparedness against sophisticated threats. It collaborates with the University of Nebraska System to provide innovative research, technology, training, and expertise to improve the U.S. capability to deter, interdict, and respond to strategic threats.

Imbed Biosciences is a privately held medical device company that specializes in the development of advanced devices for the treatment of burns, ulcers, and soft-tissue repair. The company is committed to providing innovative solutions that improve patient care and outcomes through its patented Microlyte® Matrix technology.

MediWound Ltd. is a global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair. The company specializes in the development, production, and commercialization of rapid and effective biologics that enhance existing standards of care, improve patient experiences, and reduce costs and unnecessary surgeries.

Battelle is an independent nonprofit organization dedicated to advancing science and technology to address the world's most pressing challenges. With over 90 years of experience, Battelle transforms knowledge into profound innovation, reinvesting its proceeds into scientific advancement and STEM education. The organization operates across various markets, including health, national security, environment, infrastructure, and industry, providing solutions through limitless innovation and expertise in scientific and engineering disciplines.

Relevium Medical is a pharmaceutical company based in Ireland and the US, founded in 2019 as a spin-out from the University of Galway’s BioInnovate Programme, the only European affiliate of Stanford BioDesign. With support from Y Combinator, Enterprise Ireland and the European Innovation Council, the company is developing novel hydrogel-based therapeutics for chronic disorders, leveraging natural biopolymers and active agents for targeted, long-lasting treatment. Relevium has a world-class clinical advisory board and a growing pipeline including products for osteoarthritis, painful bladder, neurogenic bladder, & trauma wound infections. To date the company has secured a total of $8 million non-dilutive funding and private seed investment.

TecTraum Inc. is pioneering the advancement of concussion therapy with the development of Pro2cool®, the world’s first FDA-designated Breakthrough Device for post-concussion cooling therapy. The company’s mission is to provide a safe, effective, and easy-to-use medical device that can be deployed in various settings to reduce the signs and symptoms of concussion, particularly in athletes. TecTraum emphasizes science before sales, conducting extensive clinical trials to validate the safety and efficacy of its technology. Our vision is to revolutionize concussion treatment and improve patient outcomes. Pro2cool® works by using selective localized external cooling of the head and neck. The technology leverages hypothermic therapy, or cold therapy, in the form of a precisely controlled thermoelectric cooling device and garment applied to the head and neck. Once the pro2cool® is in place, the chiller assembly reduces the temperature of a coolant mixture in the device to 6°C and circulates it through the cooling garment to create precision conductive heat transfer from the head and neck. The physiologic neuroprotective benefit from cooling the injured region occurs at the cellular level. By interrupting the body’s naturally occurring localized inflammatory response with the introduction of cold therapy, the cellular- based metabolic cascade is dampened, thereby minimizing the ensuing damage caused by the body in response to injury. Pro2cool® imparts a proven significant clinical difference through just two treatments at 6°C administered for 30 minutes each, separated by 72 hours from the time of diagnosis. Extensive data derived from a large pivotal clinical trial supports the efficacy of the device. The multisite trial, completed in 2022, was designed to enroll patients between the ages of 12 and 21. It is the first and only concussion treatment study of this population. Four leading pediatric medical centers – three in Ohio and one in Michigan – served as investigational sites: Akron Children’s Hospital, Cincinnati Children’s Hospital Medical Center, Dayton Children’s Hospital, and the University of Michigan’s C.S. Mott Children’s Hospital. In addition to the Breakthrough Device Designation, Pro2cool® has been studied in the largest known clinical trial for concussion therapy; has been issued a first ever Category III CPT reimbursement code by the American Medical Association; and, TecTraum has completed Quality System audits, and received certification as an FDA 13485 registered medical device manufacturer. The company is awaiting FDA clearance under the De Novo regulatory approval pathway. TecTraum has begun production and is looking to partner with the Department of Defense as well as MTEC members to demonstrate the unique and important capabilities of Pro2cool® in support of our Nation’s Warfighters.

TechConnect is dedicated to catalyzing innovation for positive change by connecting technologists, entrepreneurs, government leaders, and industry stakeholders. The organization facilitates partnerships and collaboration through events, challenges, and innovation programs, aiming to address critical challenges across various sectors including smart cities, advanced manufacturing, and space technology.

Northeastern University is a global research university founded in 1898, renowned for its experiential learning model, high-impact research, and deep partnerships. The university emphasizes innovative teaching and research that engage students, faculty, and alumni in solving real-world problems, fostering a dynamic and inclusive community across its 13 campuses worldwide.

Rebel Medicine is a science-led pharmaceutical company dedicated to revolutionizing acute pain management by developing innovative, non-opioid solutions. Their mission is to create impactful products that improve patient outcomes and reduce healthcare costs. By leveraging novel drug delivery technologies, Rebel Medicine aims to provide effective pain management solutions that eliminate the need for opioids, thus addressing a significant unmet medical need in acute and postoperative pain management.

The University of Montana (UM) is a flagship public research university located in Missoula, Montana. Established in 1893, UM offers a wide range of undergraduate and graduate programs, emphasizing research, creativity, and community engagement. With a commitment to academic excellence and public service, UM aims to transform lives through education and research, fostering a diverse and inclusive environment for its students.

The University at Buffalo is a leading public research university and flagship of the SUNY System, recognized for its innovative research and commitment to societal impact. It aims to transform scientific and technological breakthroughs into global impact, addressing complex challenges through interdisciplinary collaboration.

ZOLL Medical Corporation, a subsidiary of Asahi Kasei, is a global leader in developing and marketing medical devices and software solutions aimed at advancing emergency care and improving patient outcomes. Founded in 1980 and named after Dr. Paul Zoll, the company is renowned for its innovative technologies in defibrillation, cardiac monitoring, and other critical care solutions. ZOLL is committed to enhancing clinical and operational efficiencies, supporting healthcare professionals and lay rescuers worldwide in addressing serious cardiopulmonary and respiratory conditions.

UC San Francisco is a leading university dedicated to advancing health worldwide through preeminent biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. With a commitment to public service, UCSF aims to innovate health care approaches for vulnerable populations and train the next generation of health professionals.

Brinter is a pioneering US-based MedTech firm focused on revolutionizing tissue engineering through the development of 3D bioprinted biocomposite regenerative implants, known as BioMods™, which aim to restore damaged tissue and replace conventional implants, launching in orthopedics/tendons and ligaments. The company driven by a team of visionary entrepreneurs and leading bioscientists and engineers.

Cook MyoSite, a subsidiary of Cook Group, has been advancing human muscle cell technology since 2002. Operating under ISO 9001:2015-certified quality standards, we specialize in primary human skeletal muscle-derived cells and fibro-adipogenic progenitors sourced from healthy donors and individuals with neuromuscular, metabolic, and rare disorders. Our offerings include custom cell procurement, specialized media formulations, and contract manufacturing services—supporting both academic research and clinical development in regenerative medicine. Beyond research tools, Cook MyoSite is pioneering autologous muscle-derived cell therapies. Our investigational product, iltamiocel, is currently in a Phase III clinical trial for fecal incontinence, demonstrating our commitment to translating cell-based science into real-world solutions. With expertise in GMP manufacturing, analytical testing, and tailored partnerships, we empower collaborators to accelerate innovation in musculoskeletal and neuromuscular health worldwide.

NeuEsse Inc. is dedicated to advancing skin health through innovative plant-based technologies. Their mission is to provide effective solutions for skin repair, addressing challenges such as severe burns, wounds, and trauma. Their flagship product, OmegaSkin™, is a human skin substitute made from soy protein, designed to enhance healing outcomes with minimal scarring. NeuEsse aims to meet the unmet needs in wound treatment, offering products that are sustainable, vegan-friendly, and require no special handling.

Oridivus is pioneering the development of the first FDA-approved oral wound healing therapy, with a mission to transform pediatric oral health outcomes. The company addresses critical unmet needs in oral surgery by accelerating healing, reducing pain, and minimizing opioid dependency, especially in young patients. Oridivus leverages advanced biomaterials and immunomodulatory compounds to provide faster, safer, and more effective recovery for procedures such as wisdom tooth extractions, cleft palate repairs, and oral trauma. Their vision is to improve quality of life for children and young adults, break the cycle of opioid dependency, and set new standards in oral wound care.

SUNY Upstate Medical University is a leading academic medical center in Central New York, dedicated to providing exceptional patient care, advancing medical research, and educating future healthcare professionals. As the region's only Level I trauma center and a Magnet recognized institution, Upstate is committed to delivering cutting-edge, life-saving treatments and fostering a compassionate, patient-centered environment. The university also plays a significant role in the community through outreach programs and is recognized as one of America's best large employers by Forbes.

Hemanext is a privately held medical technology company specializing in oxygen-controlled red blood cell processing and storage systems for transfusion medicine. The company develops, manufactures, and commercializes innovative storage solutions that preserve the quality and function of red blood cells by limiting oxygen and carbon dioxide exposure, with the goal of improving transfusion outcomes for patients with chronic and acute conditions. Hemanext's products have received FDA De Novo marketing authorization and CE Mark certification, enabling global distribution. The company is recognized for its focus on scientific evidence, operational compatibility, and strategic partnerships with blood establishments and clinical researchers.

SelSym Biotech is dedicated to developing innovative therapeutics to address critical clinical needs in hemorrhage control, surgical bleeding, and wound healing. Their mission is to transform patient care and outcomes through advanced technologies like their Hemostatic Healing Hydrogels and SymClot, a novel therapy that mimics platelet functions to enhance hemorrhage control and address platelet supply shortages.

Washington State University (WSU) is a public research university dedicated to improving lives by serving the public good. With a commitment to unlocking possibilities, WSU empowers students, faculty, and others to create a world where all people can thrive. The university offers a diverse range of academic programs across its six campuses and is recognized for its high research activity and community engagement.

SutureTech is a surgeon-founded medical device company based in Durham, North Carolina, specializing in the development of innovative internal fixation implants and surgical instruments for soft tissue and tendon repair. The company is dedicated to advancing orthopedic procedures by delivering clinically informed, surgeon-driven solutions that streamline surgical steps, enhance repair strength, and improve patient outcomes. SutureTech's flagship product, RapidFix™, is an all-suture dual anchor system designed for efficient, reliable fixation of soft tissue to bone, and has received FDA 510(k) clearance.

Pressure Medical develops advanced medical devices focused on severe hemorrhage control and trauma care, particularly for military and high-risk civilian environments. The company specializes in smart pneumatic and junctional tourniquets designed for rapid and effective bleeding control in emergency situations, emphasizing ease of use, minimal training requirements, and patient limb preservation. With multiple issued patents and collaborations with government and defense agencies, Pressure Medical aims to enhance combat medical care and improve survival outcomes through innovative biomedical engineering.

Altrazeal Life Sciences Inc. is a specialty medical technology company dedicated to developing and commercializing innovative drug delivery systems. Their mission is to improve patient outcomes by providing comprehensive solutions for patients, providers, and payers. The company is known for its patented Altrazeal® Transforming Powder Dressing, which optimizes the wound healing environment and supports tissue repair.

UCLA is a leading public research university located in Los Angeles, California. It is renowned for its commitment to the creation, dissemination, preservation, and application of knowledge for the advancement of global society. With a rich history of academic and athletic excellence, UCLA offers a comprehensive environment that supports both academic and personal growth. The university is dedicated to fostering innovation and making a significant impact on the world through groundbreaking research and transformative practices.

Riptide Bioscience develops engineered peptides derived from host defense peptides found widely in nature. Their focus is on creating peptide-based therapeutics for cancer, inflammatory diseases, and microbial infections, especially those resistant to conventional treatments. The company advances both preclinical and early-stage clinical programs, collaborates with academic partners and government agencies, and holds patents for its engineered peptide design technologies.

Rx Bandz is dedicated to developing innovative, next-generation auto-injectors and life-saving formulations that provide simple solutions for patients, first responders, and the military. Their mission is to enhance the delivery of injectable medications, ensuring accessibility and ease of use for anyone, anytime, anywhere.

Arizona State University (ASU) is a comprehensive public research university known for its commitment to inclusivity, excellence, and societal impact. ASU is dedicated to advancing research-based solutions for global challenges, fostering strong leadership, and providing quality education accessible to all learners. The university is recognized for its innovative approach to education and its efforts in sustainability, research, and community service. ASU exemplifies a new prototype for the American public research university, focusing on excellence, broad access to quality education, and meaningful societal impact.

Invisible Wounds Foundation is a 501(c)(3) nonprofit organization dedicated to safeguarding the brain health of elite warriors, particularly Special Operations Forces (SOF). Founded in 2022 by Shannon Connell, the organization addresses the critical gap in research, diagnosis, and care for traumatic brain injuries (TBI) among SOF personnel. With a mission to advance science for the diagnosis, treatment, and prevention of combat-related brain injuries, Invisible Wounds Foundation brings together leading experts, catalyzes high-impact research, and advocates for innovative solutions. Their vision is a future where no service member suffers from the invisible wounds of TBI. The Foundation leads the Special Operations Forces Brain Health Initiative, building strategic partnerships, funding research, and uniting top experts to advance diagnostics, treatment, and prevention strategies for blast-induced TBI. The Foundation also fosters community engagement through events and volunteer opportunities, furthering awareness and support for TBI research and care.

The Medical College of Wisconsin (MCW) is dedicated to transforming healthcare through innovative education, research, and patient care. With a focus on academic medicine, MCW aims to improve the health of communities by fostering a collaborative learning environment that integrates medical education with groundbreaking research and comprehensive patient care.

Partner Therapeutics, Inc. (PTx) is a commercial-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for cancer and other serious diseases. With a strong foundation in oncology, PTx also leads research in infectious diseases, immunology, and urgent clinical needs such as COVID-19 and sepsis. The company integrates research, manufacturing, development, and commercialization to rapidly bring therapies to patients worldwide, emphasizing collaboration with medical and scientific communities to improve patient outcomes and quality of life. PTx's mission-driven approach is supported by a leadership team with deep industry experience and a commitment to advancing late-stage therapeutics that address significant unmet medical needs. The company also maintains a robust compliance program in accordance with state and federal regulations.

Devah Therapeutics specializes in repurposing proven pharmaceutical molecules, applying contemporary scientific approaches to address stress-related, metabolic, and neuropsychiatric conditions that lack effective treatments. By utilizing the FDA 505(b)(2) regulatory pathway, the company accelerates drug development, minimizes clinical risk, and explores new indications for molecules with established safety. Their focus is on restoring resilience and quality of life through therapies underpinned by mechanism-based science. The company's lead program is based on a chemistry estate with decades of safe use, targeting multiple indications through targeted modulation of neurobiological and metabolic pathways.

Ship of Theseus is a therapeutics company pioneering the development of degradation-resistant biologics based on the homeobox (HOX) family of transcription factors. By making proprietary modifications to HOX proteins, the company overcomes natural cellular mechanisms that rapidly degrade these powerful regulators, enabling their use as pharmaceuticals with longer-lasting effects. Their mission is to unlock the therapeutic potential of HOX proteins for a range of indications, including chronic wounds, stem cell expansion, and more, by creating innovative biologics that can safely and effectively modulate cell behavior.

Imperial College London is a world-leading university focused on science, technology, engineering, medicine, and business. It is dedicated to addressing global challenges through innovative research and education, fostering a diverse and inclusive community of students and staff.

Diadem Biotherapeutics is a biotechnology company focused on developing first- and best-in-class therapeutics by engineering extracellular vesicles to modulate immune responses. Their mission is to innovate beyond existing solutions to address unmet medical needs, leveraging expertise in immunology, bioengineering, and drug development. The company’s proprietary DECOSTAR™ platform enables precise costimulatory activation or repression of immune cells, targeting a range of diseases including cancer and autoimmunity.

Crescel is a pioneering skincare company that integrates nature and science to heal the skin. Founded by master biochemist Peter J. Passalacqua, Crescel focuses on restoring skin health through innovative products that enhance the body's natural cellular repair processes, particularly leveraging the power of mitochondria.

Amsel Medical Corporation specializes in the development and commercialization of minimally invasive medical devices for trauma, vascular, and general surgical applications. Its core innovation centers on unique temporary and permanent vessel clamping technologies delivered via needle guidance. For trauma, the company is developing a field-deployable precision hemorrhage control solution for combat and civilian non-compressible junctional hemorrhage injuries . The solution can adjust the degree of vessel occlusion and distal perfusion, minimizing the potential consequences of prolonged limb ischemia and "reperfusion injury", and most importantly extends the "golden hour" for safe evacuation. Saving Limbs...Saving Lives.

Indiana University is dedicated to building a better future through education, research, and community engagement. With a commitment to academic excellence, IU offers a diverse range of programs across its nine campuses, fostering an inclusive environment for over 90,000 students from around the world. IU is also at the forefront of groundbreaking research, particularly in areas such as brain health and Alzheimer's disease.

MyFitStrip is dedicated to enhancing oral and metabolic health through clinically-supported products that utilize the therapeutic potential of prebiotic formulations to boost nitric oxide levels. Delivered via topical oral lozenges and chewing gums, these products rapidly increase local nitric oxide concentrations to support a healthy oral microbiome and suppress pathogenic organisms in the oral and nasal cavities, which are key entry points and reservoirs for many infections, including COVID-19. By focusing on oral microbiome optimization, MyFitStrip promotes nitric oxide bioavailability, a molecule vital for vascular function, immune defense, and systemic wellness. The company's product line includes prebiotic chewing gums, slow-release lozenges, and personalized saliva test strips, all designed to support cardiovascular health, physical performance, respiratory resilience, and overall oral health.

Akthelia Pharmaceuticals is a pioneering biopharmaceutical company focused on developing therapeutics that enhance the body's innate defense mechanisms to combat debilitating diseases. The company targets mucosal barrier injury and epithelial integrity through a novel immunotherapeutic strategy. Its mission is to revolutionize treatment for diseases such as cancer, infection, and autoimmune disorders by leveraging the body's own microbial defense mechanisms.

UConn Health is a vibrant, integrated academic medical center that is entering an era of unprecedented growth in academics, research, and clinical care. The campus hosts the Schools of Medicine and Dental Medicine with their respective graduate research programs, medical and dental clinics, and the UConn John Dempsey Hospital, rated as one of the World’s Best Hospitals for Infection Prevention and Patient Experience, and one of America’s Best-in-State Hospitals by Newsweek for the past four years. Recent investments in infrastructure, including new construction and renovated laboratory and teaching spaces, demonstrate a commitment to providing our faculty with access to the best possible infrastructure for scientific discovery, supporting Connecticut's and our region's need for innovation in service of our patients, transformative research, and society. We empower faculty, students, and industry partners to advance solutions that benefit Connecticut and the world, driving innovation, discovery, and societal impact through robust partnerships, state-of-the-art facilities, and a collaborative environment.

SereNeuro Therapeutics is focused on discovering and developing advanced therapies for pain relief, emphasizing non-opioid solutions. The company is committed to pioneering innovative treatments to address unmet medical needs in pain management.

The University of Tennessee, Knoxville is dedicated to advancing knowledge and understanding through research, scholarship, and creative work. The Office of Research, Innovation, and Economic Development supports faculty, staff, and students in developing competitive proposals and fostering a strong culture of research integrity, aiming to create a more just, prosperous, and sustainable world.

The Geneva Foundation is a 501(c)3 nonprofit established in 1993, dedicated to advancing military medicine through research, development, and education. With a commitment to ensuring optimal health for service members and the communities they serve, Geneva collaborates with various partners to drive innovative medical research and improve healthcare outcomes.

SIENI Holdings is a pioneering biotech company focused on developing localized therapies for the treatment of musculoskeletal conditions, including inflammation, infection, pain, and the prevention of post-surgical complications. Their mission is to enable faster healing and safer recovery by minimizing systemic drug exposure through their innovative AEGEAL platform, which delivers FDA-approved drugs directly to the site of injury or surgery. SIENI's vision is to provide versatile, precise, and bioresponsive solutions adaptable across orthopedic, trauma, burn, and veterinary applications, addressing a significant global health burden and market opportunity.

OrthoTreat is dedicated to advancing bone regeneration through innovative solutions that enhance the body's physiological healing mechanisms. Their unique approach, OsteoRegulation, focuses on optimizing biological processes rather than merely providing materials for bone formation, aiming for faster, better, and stronger healing outcomes.

The Icahn School of Medicine at Mount Sinai, located in New York City, is an international leader in biomedical education, research, and patient care. As the academic partner of the Mount Sinai Health System, the school is renowned for its innovative education, groundbreaking research, and commitment to health equity. With over 7,000 faculty, 1,200 students, and 2,500 residents and fellows, the institution fosters a culture of bold thinking, multidisciplinary teamwork, and a willingness to challenge conventional wisdom. Its mission is to radically advance the art and science of medical care through collaborative learning, scholarly inquiry, and a deep respect for diversity, preparing the next generation of healthcare leaders to revolutionize medicine and biomedical science.

Signature Science, LLC is a multidisciplinary applied science and technology company dedicated to solving the toughest forensic, biosecurity, and public health challenges. Serving both government and commercial clients, Signature Science combines scientific rigor with proven quality assurance to enhance the credibility and defensibility of programs in national security, public safety, and health security. The company is recognized for its innovation, technical excellence, and commitment to advancing the state-of-the-art in forensic science, genomics, and biosecurity technologies. Signature Science also offers advanced bioinformatics and microbiome analysis services, empowering clients with data-driven insights to address emerging threats, pandemics, and bioterrorism. The company is a subsidiary of Southwest Research Institute and is committed to community engagement and workforce development.

The Coalition for National Trauma Research (CNTR) is dedicated to saving lives and reducing disability through trauma research. Their mission focuses on coordinating research efforts, strengthening infrastructure for multi-center investigations, and advocating for sustainable research funding to address the burden of traumatic injuries.

The Center for Military Medicine Research (CMMR) at the University of Pittsburgh is dedicated to advancing medical research for wounded service members and their families. The center focuses on trauma, emergency, and critical care, leveraging the university's strengths in medical and engineering fields, and collaborating with Carnegie Mellon University's robotics and AI expertise. CMMR aims to enhance trauma care for warfighters and civilians, contributing to the defense innovation economy.

The Texas A&M Engineering Experiment Station (TEES) is a state agency and part of the Texas A&M University System, dedicated to improving lives through engineering research, workforce development, and technology transition. TEES collaborates with industry, academia, and government to provide innovative solutions to global technical challenges.